stensgaard81

stensgaard81

Globalstar ( AMEX:GSAT ) is positioned to lead the charge in satellite-enabled 5G and IoT connectivity. With a transformative Apple partnership, Band n53 spectrum dominance, and a Nasdaq uplisting on the horizon, this stock offers high-conviction long-term potential. Key Catalysts: 1. Apple Partnership: • Apple’s $1.7B investment includes a 20% equity stake in...

stensgaard81

Globalstar, Inc. (GSAT) has been thrust into the spotlight following major announcements related to Apple collaborations, 5G technology developments, and a strong strategic push toward satellite-enabled connectivity. The stock has seen increased market interest due to a combination of technical and fundamental catalysts. Key Fundamental Catalysts: 1. Apple...

stensgaard81

**Technical Indicators:** - **RSI (Relative Strength Index):** The RSI has shown multiple bullish signals recently, indicating potential upward momentum. - **MACD (Moving Average Convergence Divergence):** A bullish crossover in the MACD suggests increasing positive momentum, signaling a potential upward trend. - **Volume Trends:** Increased buying volume...

stensgaard81

Biofrontera Inc., BFRI, is a biopharmaceutical company that develops and provides dermatological products for the treatment of skin diseases in the US. It primarily develops therapies for non-melanoma skin cancer. It offers Ameluz, an aminolevulinic acid hydrochloride gel for the photodynamic therapy of actinic keratoses; and BF-RhodoLED, an LED lamp emitting red...

stensgaard81

The Biotech company Evaxion Biotech, EVAX, who develop drugs based on AI platforms, is poised to publish data from its phase 1/2a trials of EVX-01 and EVX-02 in the first half of 2021. According to Yahoo Finance there are currently two analysts with price targets for the share, $18 and $23. Evaxion is an AI-immunology platform company decoding the human immune...

stensgaard81

EVAX - Evaxion Website: evaxion-biotech.com Industry: Pharma Evaxion is an AI-immunology platform company decoding the human immune system to discover and develop novel immunotherapies for cancer and infectious diseases. Evaxion have developed an AI-immunology core technology to deeply understand the biological processes relevant for engaging the immune system...

stensgaard81

T2 Biosystems T2SARS-CoV-2™ Panel Proves Capable of Detecting the Brazil P.1 Variant of the SARS-CoV-2 Virus T2 Biosystems, Inc. Thu, February 4, 2021, 10:05 PM·5 min read TTOO +7.14% Panel is capable of detecting 99.99% of all currently identified SARS-CoV-2 viruses based on sequence alignments and in silico analysis LEXINGTON, Mass., Feb. 04, 2021 (GLOBE...

stensgaard81

I see a potential short squeese on SPCE comming up. SPCE is massivly shorted and the stock is gaining. Short Percent of Float: 81.53 % Shares Float: 53,650,000 Short Interest (Shares Short): 43,740,000 Short Interest Ratio (Days To Cover): 3.1 % From 52-Wk High ($ 57.86): 4.50% % From 50-Day MA ($ 27.24): 54.35% % From 200-Day MA ($ 20.59): 104.27% % From 52-Wk...

stensgaard81

Moneygram at bottom of Channel.

stensgaard81

Moneygram at bottom of Channel.

stensgaard81

Ascending triangle, higher lows, moving up.

stensgaard81

Test of previous resistance on the daily.

stensgaard81

Moving up into Channel..

stensgaard81

Higher lows